Related Experiment Video
Updated: Jun 5, 2025

Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
Demographic diversity in platelet function and response to antiplatelet therapy
Kanika Jain1, Tarun Tyagi1, Sean X Gu2
1Yale Cardiovascular Research Center, Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA; Yale Cooperative Center of Excellence in Hematology, Yale School of Medicine, New Haven, CT, USA.
Platelet activation drives cardiovascular disease (CVD) risk. Demographic factors significantly influence CVD and antiplatelet therapy response, necessitating personalized treatment strategies.
Area of Science:
- Cardiovascular Biology
- Hematology
- Immunology
Background:
- Platelets play crucial roles beyond hemostasis, contributing to thrombosis and inflammation in cardiovascular disease (CVD).
- Pathological platelet activation is a central mechanism in the development of cardiovascular events.
- Demographic factors like age, sex, race, and ethnicity are increasingly recognized as significant influencers of CVD risk.
Purpose of the Study:
- To review current knowledge on platelet biology in the context of cardiovascular disease.
- To highlight the impact of demographic variations on CVD risk and antiplatelet therapy efficacy.
- To advocate for demographic-specific research and tailored therapeutic strategies in CVD.
Main Methods:
- Literature review of recent studies on platelet function and cardiovascular disease.
- Analysis of research focusing on demographic influences (age, sex, race, ethnicity) on CVD and treatment responses.
- Synthesis of findings to identify knowledge gaps and future research directions.
Main Results:
- Platelet biology is complex, with roles extending beyond hemostasis to inflammation and thrombosis in CVD.
- Demographic factors significantly affect individual CVD risk and response to antiplatelet medications.
- Genetic and non-genetic factors underlie population-based differences in platelet function and disease outcomes.
Conclusions:
- Understanding demographic influences on platelet behavior is critical for effective CVD management.
- Current antiplatelet strategies may require reevaluation to account for population-specific differences.
- Tailored therapeutic approaches based on demographic profiles are essential for optimizing cardiovascular outcomes.
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

